Get startedLog in
    Picture of Algorae Pharmaceuticals logo

    1AI — Algorae Pharmaceuticals News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Living Cell Technologies Secures Funding For Third Clinical Trial Of NTCELL In Parkinson's Disease

    Picture of Algorae Pharmaceuticals logoAlgorae Pharmaceuticals
    19/10/2021 01:54
    Oct 19 (Reuters) - Living Cell Technologies Ltd  LCT.AX :
    * SECURED FUNDING FOR A THIRD CLINICAL TRIAL OF NTCELL IN
PARKINSON'S DISEASE
    * COMPLETED PLACEMENT RAISING A$3.5 MILLION

Source text for Eikon:  ID:nASXbgXbmM 
Further company coverage:  LCT.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Algorae Pharmaceuticals

    See all news